- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Adaptive Video files for liquidation
Systems connectivity developer Adaptive Video has filed for Chapter7 bankruptcy in a federal court in Santa Rosa, CA, according toStephen O'Neill, an attorney for the Novato, CA, vendor. The company'soperations have ceased and its backers are pursuing a
Systems connectivity developer Adaptive Video has filed for Chapter7 bankruptcy in a federal court in Santa Rosa, CA, according toStephen O'Neill, an attorney for the Novato, CA, vendor. The company'soperations have ceased and its backers are pursuing a plan tosell the rights to its technology to mobile mammography firm TexasMobile Health.
Adaptive Video announced in February that it was in the processof being merged with Texas Mobile Health (SCAN 2/14/96). But thatdeal fell through, and Adaptive Video's venture capital backersdecided to put the company into Chapter 7 liquidation.
Texas Mobile Health is still interested in Adaptive Video'stechnology, however, according to Texas Mobile Health presidentChelette Baker. The Houston company is planning to form a newholding company, Basic Solutions International, that will includeTexas Mobile Health and a new company to be formed to market AdaptiveVideo's technology.
"We are still in the process of doing the same thing,(but) it's coming through a different legal route," Bakersaid. "We will utilize (Adaptive Video) technology in someof the mobile work we are doing. We will also set up somethingunder Basic Solutions for the teleradiology and telemedicine technology."
Can Portable Dual-Energy X-Ray be a Viable Alternative to CT in the ICU?
September 13th 2024The use of a portable dual-energy X-ray detector in the ICU at one community hospital reportedly facilitated a 37.5 percent decrease in chest CT exams in comparison to the previous three months, according to research presented at the American Society of Emergency Radiology (ASER) meeting in Washington, D.C.
New Meta-Analysis Examines MRI Assessment for Treatment of Esophageal Cancer
September 12th 2024Diffusion-weighted MRI provided pooled sensitivity and specificity rates of 82 percent and 81 percent respectively for gauging patient response to concurrent chemoradiotherapy for esophageal cancer, according to new meta-analysis.
Study for Emerging PET/CT Agent Reveals ‘New Standard’ for Detecting Clear Cell Renal Cell Carcinoma
September 11th 2024Results from a multicenter phase 3 trial showed that the PET/CT imaging agent (89Zr)Zr-girentuximab had an 85.5 percent mean sensitivity rate for the diagnosis of clear cell renal cell carcinoma.
Can Radiomics and Autoencoders Enhance Real-Time Ultrasound Detection of Breast Cancer?
September 10th 2024Developed with breast ultrasound data from nearly 1,200 women, a model with mixed radiomic and autoencoder features had a 90 percent AUC for diagnosing breast cancer, according to new research.
